SmithRx will be First PBM to Offer YUSIMRY, a Humira Biosimilar, for One-Tenth the List Price of Humira
June 13, 2023 09:00 ET
|
SmithRx
SAN FRANCISCO, June 13, 2023 (GLOBE NEWSWIRE) -- SmithRx, a next-generation pharmacy benefits management (PBM) company, announced today that it will offer YUSIMRY, a biosimilar of Humira, to its...